Update: Sell-Off In Biopharmaceutical Stocks- BIIB, PCYC, REGN
Big Large Cap Winners Down-Volatilty Increasing ETFS: IBB $257 down 1.57%, PBE $45.25 down 1.2% , XBI $159.7 down 1.17% The profit taking which actually began last Friday and, after a brief recovery, resumed yesterday accelerating today. Large caps are leading the way down. Notable losers...
Clinical Diagnostic Companies 2013 Financial Metrics and Valuation Models
Diagnostics Companies-After 2013 Financial Reporting Stocks to Watch: Cepheid (CPHD), Exact Sciences (EXAS) , Orasure (OSUR) Price to Sales (P/S) is the best metric of value as many companies in the sector are not profitable. Molecular diagnostics and genomics are the strongest growth sectors...
Geopolitical Risk Deemed Minimal In Biotech… Update Sell-Off 3/6/14
Stealth Biotech Sell-Off-Caution Urged-Red Screen Aegerion (AEGR $50) down 7%, Medivation (MDVN $66.9) off 5%, Puma (PBYI $113.5) off 5.4%, IBB ($261.75) off 2.8% , XBI ($161.9 off 3% etc. ----------from 5/4-------- Most Biotech Stocks Recover From Two Day Sell-Off Stocks Surge After Ukraine...
A Good Week For Rayno Life Science Stocks: AMRI, CBST, ILMN, RHHBY
Rayno Life Science Movers -Diagnostics Review Next Week Despite some choppiness in biotech trading this week many of our stocks did well. I won't go into some of the unusual volatility in other small and mid-caps lately but that is part of the reason for my "bubble" article. There is also a...
Biotech Bull Market: OK Let’s Just Call It A Bubble
Biotech May Be A Bubble-But What to Do? The blogosphere is trying to temper bullish sentiment with a lot of "bubble "talk even though the cable channels are still pumping biotech. If you have been around biotech for 25 years especially during the last true bubble -1999 -you should be a little...